Sotrastaurin
- Generic Name
- Sotrastaurin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H22N6O2
- CAS Number
- 425637-18-9
- Unique Ingredient Identifier
- 7I279E1NZ8
- Background
Sotrastaurin has been used in trials studying the basic science and treatment of Uveal Melanoma, Richter Syndrome, Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma, and Recurrent Small Lymphocytic Lymphoma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
CAEB071 Thorough QTc Study in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-05-09
- Last Posted Date
- 2012-05-09
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT01594255
- Locations
- 🇺🇸
Novartis Investigational Site, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath